Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 389.6 Million USD | 20.03% |
| 2022 | 324.58 Million USD | 2.27% |
| 2021 | 317.38 Million USD | 2.34% |
| 2020 | 310.11 Million USD | -1.88% |
| 2019 | 316.05 Million USD | 12.74% |
| 2018 | 280.34 Million USD | -5.39% |
| 2017 | 296.33 Million USD | 36.39% |
| 2016 | 217.26 Million USD | 2.76% |
| 2015 | 211.42 Million USD | -10.83% |
| 2014 | 237.11 Million USD | 11.1% |
| 2013 | 213.43 Million USD | 24.23% |
| 2012 | 171.8 Million USD | 0.32% |
| 2011 | 171.26 Million USD | 16.56% |
| 2010 | 146.92 Million USD | 4.77% |
| 2009 | 140.24 Million USD | -4.01% |
| 2008 | 146.1 Million USD | 1.08% |
| 2007 | 144.53 Million USD | 53.13% |
| 2006 | 94.38 Million USD | 39.88% |
| 2005 | 67.47 Million USD | 20.61% |
| 2004 | 55.94 Million USD | 36.3% |
| 2003 | 41.04 Million USD | 44.01% |
| 2002 | 28.5 Million USD | 15.82% |
| 2001 | 24.6 Million USD | 49.07% |
| 2000 | 16.5 Million USD | 63.45% |
| 1999 | 10.1 Million USD | 274.07% |
| 1998 | 2.7 Million USD | 12.5% |
| 1997 | 2.4 Million USD | -7.69% |
| 1996 | 2.6 Million USD | 85.71% |
| 1995 | 1.4 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 403.42 Million USD | 3.55% |
| 2024 Q2 | 421.77 Million USD | 4.55% |
| 2024 Q3 | 436.93 Million USD | 3.59% |
| 2023 Q2 | 354.29 Million USD | 0.86% |
| 2023 Q4 | 389.6 Million USD | 6.38% |
| 2023 Q1 | 351.27 Million USD | 8.22% |
| 2023 FY | 389.6 Million USD | 20.03% |
| 2023 Q3 | 366.25 Million USD | 3.38% |
| 2022 FY | 324.58 Million USD | 2.27% |
| 2022 Q2 | 320.2 Million USD | -2.38% |
| 2022 Q1 | 328 Million USD | 3.35% |
| 2022 Q3 | 311.06 Million USD | -2.86% |
| 2022 Q4 | 324.58 Million USD | 4.35% |
| 2021 Q3 | 327.16 Million USD | 1.1% |
| 2021 Q2 | 323.61 Million USD | -1.35% |
| 2021 FY | 317.38 Million USD | 2.34% |
| 2021 Q1 | 328.04 Million USD | 5.78% |
| 2021 Q4 | 317.38 Million USD | -2.99% |
| 2020 Q2 | 358.75 Million USD | 6.12% |
| 2020 Q3 | 307.83 Million USD | -14.19% |
| 2020 Q4 | 310.11 Million USD | 0.74% |
| 2020 FY | 310.11 Million USD | -1.88% |
| 2020 Q1 | 338.08 Million USD | 6.97% |
| 2019 Q1 | 286.96 Million USD | 2.36% |
| 2019 Q4 | 316.05 Million USD | 4.44% |
| 2019 FY | 316.05 Million USD | 12.74% |
| 2019 Q3 | 302.62 Million USD | 2.06% |
| 2019 Q2 | 296.5 Million USD | 3.33% |
| 2018 Q3 | 290.84 Million USD | 0.11% |
| 2018 FY | 280.34 Million USD | -5.39% |
| 2018 Q4 | 280.34 Million USD | -3.61% |
| 2018 Q2 | 290.51 Million USD | 0.01% |
| 2018 Q1 | 290.47 Million USD | -1.98% |
| 2017 Q1 | 239.8 Million USD | 10.38% |
| 2017 FY | 296.33 Million USD | 36.39% |
| 2017 Q4 | 296.33 Million USD | 27.54% |
| 2017 Q3 | 232.34 Million USD | -1.0% |
| 2017 Q2 | 234.68 Million USD | -2.14% |
| 2016 Q1 | 221.97 Million USD | 4.99% |
| 2016 Q2 | 220.44 Million USD | -0.69% |
| 2016 FY | 217.26 Million USD | 2.76% |
| 2016 Q3 | 219.67 Million USD | -0.35% |
| 2016 Q4 | 217.26 Million USD | -1.1% |
| 2015 Q1 | 233.04 Million USD | -1.72% |
| 2015 FY | 211.42 Million USD | -10.83% |
| 2015 Q3 | 213.87 Million USD | -11.56% |
| 2015 Q2 | 241.83 Million USD | 3.77% |
| 2015 Q4 | 211.42 Million USD | -1.15% |
| 2014 Q2 | 223.63 Million USD | 3.9% |
| 2014 Q3 | 230.45 Million USD | 3.05% |
| 2014 Q4 | 237.11 Million USD | 2.89% |
| 2014 Q1 | 215.23 Million USD | 0.84% |
| 2014 FY | 237.11 Million USD | 11.1% |
| 2013 Q2 | 195.45 Million USD | 8.85% |
| 2013 FY | 213.43 Million USD | 24.23% |
| 2013 Q4 | 213.43 Million USD | 2.91% |
| 2013 Q3 | 207.38 Million USD | 6.1% |
| 2013 Q1 | 179.55 Million USD | 4.51% |
| 2012 Q2 | 172.54 Million USD | 0.04% |
| 2012 Q3 | 169.37 Million USD | -1.83% |
| 2012 Q4 | 171.8 Million USD | 1.43% |
| 2012 FY | 171.8 Million USD | 0.32% |
| 2012 Q1 | 172.46 Million USD | 0.71% |
| 2011 Q1 | 154.6 Million USD | 5.22% |
| 2011 Q2 | 174.46 Million USD | 12.85% |
| 2011 Q3 | 181.43 Million USD | 4.0% |
| 2011 FY | 171.26 Million USD | 16.56% |
| 2011 Q4 | 171.26 Million USD | -5.6% |
| 2010 Q4 | 146.92 Million USD | -0.71% |
| 2010 FY | 146.92 Million USD | 4.77% |
| 2010 Q3 | 147.97 Million USD | 3.29% |
| 2010 Q2 | 143.25 Million USD | 0.8% |
| 2010 Q1 | 142.11 Million USD | 1.34% |
| 2009 Q3 | 140.54 Million USD | 0.88% |
| 2009 Q2 | 139.31 Million USD | -1.6% |
| 2009 FY | 140.24 Million USD | -4.01% |
| 2009 Q4 | 140.24 Million USD | -0.21% |
| 2009 Q1 | 141.58 Million USD | -3.09% |
| 2008 Q3 | 155.61 Million USD | 4.2% |
| 2008 Q1 | 144.03 Million USD | -0.34% |
| 2008 FY | 146.1 Million USD | 1.08% |
| 2008 Q2 | 149.34 Million USD | 3.69% |
| 2008 Q4 | 146.1 Million USD | -6.11% |
| 2007 Q2 | 114.08 Million USD | 19.35% |
| 2007 FY | 144.53 Million USD | 53.13% |
| 2007 Q4 | 144.53 Million USD | 14.37% |
| 2007 Q3 | 126.37 Million USD | 10.77% |
| 2007 Q1 | 95.59 Million USD | 1.28% |
| 2006 FY | 94.38 Million USD | 39.88% |
| 2006 Q3 | 93.77 Million USD | 0.85% |
| 2006 Q2 | 92.98 Million USD | 20.52% |
| 2006 Q1 | 77.15 Million USD | 14.34% |
| 2006 Q4 | 94.38 Million USD | 0.65% |
| 2005 Q1 | 65.33 Million USD | 16.78% |
| 2005 FY | 67.47 Million USD | 20.61% |
| 2005 Q4 | 67.47 Million USD | -2.23% |
| 2005 Q3 | 69.01 Million USD | -0.28% |
| 2005 Q2 | 69.2 Million USD | 5.92% |
| 2004 Q1 | 44.89 Million USD | 9.37% |
| 2004 FY | 55.94 Million USD | 36.3% |
| 2004 Q4 | 55.94 Million USD | 6.77% |
| 2004 Q3 | 52.4 Million USD | 3.74% |
| 2004 Q2 | 50.5 Million USD | 12.51% |
| 2003 Q2 | 39.07 Million USD | 4.5% |
| 2003 FY | 41.04 Million USD | 44.01% |
| 2003 Q4 | 41.04 Million USD | 6.9% |
| 2003 Q3 | 38.39 Million USD | -1.75% |
| 2003 Q1 | 37.39 Million USD | 31.2% |
| 2002 Q2 | 25.02 Million USD | 4.21% |
| 2002 Q3 | 26.57 Million USD | 6.18% |
| 2002 Q4 | 28.5 Million USD | 7.27% |
| 2002 FY | 28.5 Million USD | 15.82% |
| 2002 Q1 | 24.01 Million USD | -2.42% |
| 2001 FY | 24.6 Million USD | 49.07% |
| 2001 Q1 | 18.5 Million USD | 12.12% |
| 2001 Q2 | 22.65 Million USD | 22.38% |
| 2001 Q4 | 24.6 Million USD | 2.06% |
| 2001 Q3 | 24.11 Million USD | 6.45% |
| 2000 Q3 | 16.34 Million USD | 3.88% |
| 2000 Q1 | 10.66 Million USD | 5.61% |
| 2000 FY | 16.5 Million USD | 63.45% |
| 2000 Q4 | 16.5 Million USD | 1.02% |
| 2000 Q2 | 15.73 Million USD | 47.47% |
| 1999 Q1 | 13.1 Million USD | 385.19% |
| 1999 Q2 | 11.2 Million USD | -14.5% |
| 1999 FY | 10.1 Million USD | 274.07% |
| 1999 Q3 | 10.8 Million USD | -3.57% |
| 1999 Q4 | 10.1 Million USD | -6.48% |
| 1998 Q4 | 2.7 Million USD | -20.59% |
| 1998 Q1 | 2.4 Million USD | 0.0% |
| 1998 Q2 | 2.6 Million USD | 8.33% |
| 1998 Q3 | 3.4 Million USD | 30.77% |
| 1998 FY | 2.7 Million USD | 12.5% |
| 1997 Q3 | 1.9 Million USD | -5.0% |
| 1997 FY | 2.4 Million USD | -7.69% |
| 1997 Q1 | 2.8 Million USD | 7.69% |
| 1997 Q2 | 2 Million USD | -28.57% |
| 1997 Q4 | 2.4 Million USD | 26.32% |
| 1996 FY | 2.6 Million USD | 85.71% |
| 1996 Q3 | 3.1 Million USD | 10.71% |
| 1996 Q2 | 2.8 Million USD | 33.33% |
| 1996 Q1 | 2.1 Million USD | 50.0% |
| 1996 Q4 | 2.6 Million USD | -16.13% |
| 1995 FY | 1.4 Million USD | 0.0% |
| 1995 Q3 | 1.4 Million USD | 0.0% |
| 1995 Q4 | 1.4 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -11670.634% |
| BrainsWay Ltd. | 3.71 Million USD | -10381.786% |
| Cerus Corporation | 39.86 Million USD | -877.245% |
| Envoy Medical, Inc. | 1.4 Million USD | -27649.858% |
| electroCore, Inc. | 2.16 Million USD | -17937.407% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -85153.392% |
| IceCure Medical Ltd | 2.27 Million USD | -17025.626% |
| Inogen, Inc. | 21.84 Million USD | -1683.919% |
| OrthoPediatrics Corp. | 105.85 Million USD | -268.072% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -140046.763% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -38960799900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -3085.935% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -22463.917% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -248978.123% |
| Orthofix Medical Inc. | 222.16 Million USD | -75.368% |
| PAVmed Inc | 1.01 Million USD | -38209.576% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -1851.846% |
| RxSight, Inc. | 17.42 Million USD | -2136.427% |
| Sight Sciences, Inc. | 7.84 Million USD | -4863.792% |
| SI-BONE, Inc. | 20.24 Million USD | -1824.085% |
| TELA Bio, Inc. | 13.16 Million USD | -2860.097% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -1232.221% |
| Vivos Therapeutics, Inc. | 1.00 USD | -38960799900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -9007.246% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -169294.783% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -16436.842% |
| CVRx, Inc. | 10.98 Million USD | -3447.373% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -99780.023% |
| Bioventus Inc. | 91.33 Million USD | -326.58% |
| Venus Concept Inc. | 28.67 Million USD | -1258.655% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -15208.762% |
| LivaNova PLC | 147.88 Million USD | -163.45% |
| 908 Devices Inc. | 14.93 Million USD | -2508.167% |
| Alphatec Holdings, Inc. | 136.84 Million USD | -184.714% |
| Nemaura Medical Inc. | 1.75 Million USD | -22101.758% |
| NeuroPace, Inc. | 11.21 Million USD | -3374.3% |
| LENSAR, Inc. | 15.68 Million USD | -2383.32% |
| Apyx Medical Corporation | 9.92 Million USD | -3826.313% |
| Cutera, Inc. | 72.1 Million USD | -440.364% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -14475.683% |
| BioSig Technologies, Inc. | -103 Thousand USD | 378360.194% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -739.926% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -4824.889% |
| Axonics, Inc. | 79.94 Million USD | -387.376% |
| Outset Medical, Inc. | 49.21 Million USD | -691.645% |
| IRIDEX Corporation | 9.9 Million USD | -3833.051% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -879.998% |
| IRadimed Corporation | 12.82 Million USD | -2938.781% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -51435.45% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -147195.913% |
| Telesis Bio, Inc. | 4.02 Million USD | -9579.702% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -8361.791% |
| Varex Imaging Corporation | 277.5 Million USD | -40.399% |
| Quipt Home Medical Corp. | 18.32 Million USD | -2026.015% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -2226.991% |
| Dynatronics Corporation | 5.59 Million USD | -6864.78% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -10314.542% |
| Semler Scientific, Inc. | 445 Thousand USD | -87452.36% |
| InMode Ltd. | 45.09 Million USD | -763.972% |
| Bruker Corporation | 968.3 Million USD | 59.764% |
| Cytosorbents Corporation | 3.68 Million USD | -10486.803% |
| DexCom, Inc. | 559.6 Million USD | 30.377% |
| Align Technology, Inc. | 296.9 Million USD | -31.224% |
| Viveve Medical, Inc. | 1.47 Million USD | -26367.935% |
| ZimVie Inc. | 79.6 Million USD | -389.457% |
| Movano Inc. | 1.51 Million USD | -25650.694% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -539.992% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -248978.123% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | -146.686% |
| Profound Medical Corp. | 6.95 Million USD | -5503.257% |
| Insulet Corporation | 402.6 Million USD | 3.227% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -2525.568% |
| iCAD, Inc. | 917 Thousand USD | -42387.241% |
| Nuwellis, Inc. | 1.99 Million USD | -19409.664% |
| Biotricity, Inc. | 1.87 Million USD | -20630.424% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -2688.292% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -18399.905% |
| PAVmed Inc. | 1.01 Million USD | -38209.576% |
| BIOLASE, Inc. | 11.43 Million USD | -3307.749% |
| Beyond Air, Inc. | 2.12 Million USD | -18217.254% |
| FONAR Corporation | 2.71 Million USD | -14247.872% |
| AxoGen, Inc. | 23.02 Million USD | -1592.476% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -1629.516% |
| Inari Medical, Inc. | 42.9 Million USD | -808.177% |
| UFP Technologies, Inc. | 70.19 Million USD | -455.068% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -61823.236% |
| Tenon Medical, Inc. | 554 Thousand USD | -70226.354% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -23303.745% |
| AdaptHealth Corp. | 113.64 Million USD | -242.838% |
| Sintx Technologies, Inc. | 888 Thousand USD | -43774.775% |
| NanoVibronix, Inc. | 2.73 Million USD | -14160.908% |
| Quanterix Corporation | 22.36 Million USD | -1642.043% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -2524.153% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -587.43% |
| TransMedics Group, Inc. | 44.23 Million USD | -780.769% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -6792.057% |
| NeuroMetrix, Inc. | 1.55 Million USD | -24884.033% |
| Hyperfine, Inc. | 6.58 Million USD | -5819.295% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | -387.382% |
| Biomerica, Inc. | 2.37 Million USD | -16297.643% |
| Bone Biologics Corporation | -328.84 Thousand USD | 118578.063% |
| AVITA Medical, Inc. | 3.12 Million USD | -12381.787% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -1204.084% |